济川药业：如有新的回购计划将及时履行信息披露义务

Core Viewpoint - Jichuan Pharmaceutical (600566) stated on September 12 that if there are any new share repurchase plans, the company will strictly adhere to relevant regulations and fulfill information disclosure obligations in a timely manner [1] Group 1 - The company is open to implementing new share repurchase plans [1] - The company emphasizes compliance with regulations regarding information disclosure [1]